The UAE’s Ministry of Health and Prevention (Mohap) said it has signed an agreement with Neopharma Factory to provide some medical stocks used for emergency situations.
The list includes 103 types of pharmaceutical products, medicines for emergency cases and other drugs to further boost the health security of the country. Dr Al Amiri said Mohap continuously strengthens its medicine supply by signing agreements with drug manufacturers following the decision of the Council of Ministers No. 39 of 2015.
Dr Amin Hussein Al Amiri, the assistant undersecretary of Public Health Policy and licensing of the Mohap, accompanied by Dr Abdul Karim Abdullah Al Zarouni, the director of the Department of Emergency, Crisis and Disaster Operations, signed the agreement with Suresh Kumar Nandiraju, the chief operating officer of Neopharma.
“The Neopharma agreement is part of our efforts to improve health and medical security, and enable us to immediately respond to emergencies through the acquisition of strategic medical stocks for the ministry’s stores,” he remarked.
“This covers our requirements for one year, including stocks for three months that are readily available in the form of finished goods while the remaining quantity will be in the form of raw materials that will be used in the medicines’ manufacturing process,” he added.
Dr Amin pointed out that the Ministry works towards building quality and safety systems for treatment, health and medicine in accordance with international standards and envisions to promote a healthy society by providing comprehensive and innovative health services.
It implements a regulatory and auditor role in the health sector following an advanced and integrated health legislative system.
Dr Al Zarouni said the agreement sets a mechanism for recycling stocks and constantly offering fresh goods to consumers while maintaining the overall stock quantity required.
The ministry is responsible for storing and maintaining medical stocks according to the global storage and recycling standards, he noted.
“The list comprises a total of 103 drug categories, including 27 for the treatment of infections, 22 for the ear, nose and throat (ENT), 13 for the treatment of respiratory diseases, nine each for cardiovascular and chronic diseases, eight for gastrointestinal diseases, six for the urinary tract, gynecology and obstetrics, four each for blood diseases and malnutrition and bone diseases and one medicine for diseases of the nervous system.
Nandiraju said Neopharma was committed to serving the pharmaceutical manufacturing in the UAE.
“We are honoured to work with the Mohap to provide vital medical supplies that benefit the community during times of crisis, and to allow effective approaches to manage health care costs, increase access to essential medicines and contribute to the strengthening of the pharmacoeconomy in the country,” he added.-TradeArabia News Service